Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
ClearBridge BioMedics
ClearBridge BioMedics
Activities:
Manufacturing
Research & Development
Analysis
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Supporting circulating tumour cell (CTC) research
Clearbridge BioMedics and Leica Biosystems will co-market each other’s products to support circulating tumour cell (CTC) research
Regulatory
Clearbridge BioMedics joins CANCER-ID consortium
Clearbridge BioMedics has joined CANCER-ID, a public-private international consortium, which aims to establish standard protocols for and clinical validation of blood-based biomarkers
Manufacturing
Dolomite and ClearBridge develop ClearCell instrument
Detects circulating tumour cells and paves the way for personalised cancer treatment
Subscribe now